M&T Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-163
Closed -$27K 1592
2021
Q4
$27K Buy
163
+70
+75% +$4.82K ﹤0.01% 1541
2021
Q3
$9K Buy
+93
New +$6.53K ﹤0.01% 1548
2020
Q3
Sell
-5
Closed -$1K 1622
2020
Q2
$1K Hold
5
﹤0.01% 1581
2020
Q1
$2K Buy
+5
New +$345 ﹤0.01% 1534
2019
Q3
Sell
-10
Closed -$1K 1628
2019
Q2
$1K Buy
+10
New +$658 ﹤0.01% 1594
2018
Q4
Sell
-5
Closed -$1K 1484
2018
Q3
$1K Buy
+5
New +$378 ﹤0.01% 1547
2017
Q3
Sell
-3
Closed -$2K 1647
2017
Q2
$2K Sell
3
-8
-73% -$532 ﹤0.01% 1584
2017
Q1
$1K Buy
+11
New +$773 ﹤0.01% 1644
2016
Q3
Sell
-18
Closed -$1K 1734
2016
Q2
$1K Sell
18
-1,782
-99% -$158K ﹤0.01% 1672
2016
Q1
$2K Sell
1,800
-2,000
-53% -$180K ﹤0.01% 1694
2015
Q4
$25K Sell
3,800
-200
-5% -$20.8K ﹤0.01% 1663
2015
Q3
$25K Buy
4,000
+1,200
+43% +$133K ﹤0.01% 1720
2015
Q2
$56K Sell
2,800
-3,300
-54% -$361K ﹤0.01% 1932
2015
Q1
$34K Buy
6,100
+100
+2% +$10.2K ﹤0.01% 1932
2014
Q4
$40K Buy
6,000
+2,100
+54% +$217K ﹤0.01% 1944
2014
Q3
$72K Buy
+3,900
New +$382K ﹤0.01% 2046

Other funds holding GILD

M&T Bank's GILD Position: Q1 2026 in Review

M&T Bank reduced its Gilead Sciences (GILD) stake by 5.4% in Q1 2026, selling an estimated $1.43M and leaving 180,912 shares worth $25.2M. The position accounts for 0.09% of the portfolio, ranked #178.

M&T Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $73M in Q2 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • M&T Bank held 180,912 shares of Gilead Sciences worth $25.2M as of Q1 2026.
  • M&T Bank sold 10,229 Gilead Sciences shares in Q1 2026, an estimated $1.43M.
  • Gilead Sciences made up 0.09% of M&T Bank's portfolio in Q1 2026, its #178 holding.
  • M&T Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • M&T Bank's Gilead Sciences position peaked at $73M in Q2 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.